Company Pulls COVID-19 Treatment From European Medicines Agency Review, Citing Lack Of Demand

Reuters (11/2, Aripaka, Burger) reports Eli Lilly “has retracted a request for European Union approval of its antibody-based treatment for COVID-19, citing a lack of demand from EU member states as the bloc focuses on other suppliers.” The European Medici...